Johnson & Johnson Launches 'Boao Innovation Chain 2.0' to Advance Healthcare Innovation

And "Neurosurgery Innovation Strategy Platform" Signing Ceremony for Letter of Intent

BoaoFebruary 18, 2023 /PR Newswire/ --Today, Johnson & Johnson, a globally leading diversified healthcare company, announced the "Johnson & Johnson Boao Innovation Chain2.0" Setting Sail Anew. The brand-new "Johnson & Johnson Boao Innovation Chain" will build upon the existing foundation of innovation introduction and academic exchange collaborations, and work together withHainanBoao Lecheng International Medical Tourism Pilot Zone further explores cooperation and co-construction in the transformation of scientific and technological achievements, incubation of innovative projects, promotion of industry standards, and the development of an innovative ecosystem, aiming to boost the innovative development of the healthcare industry. As part of the "Johnson & Johnson Boao Innovation Chain"One of the key initiatives of "2.0" is that today, Johnson & Johnson Medical Technology signed a letter of intent with the Hainan Lecheng Real-World Research Institute to establish a "Neurosurgical Innovation Strategic Platform." This aims to create a positive medical technology innovation ecosystem in the field of neurosurgery, promoting the transformation of medical engineering and discipline development.

"Johnson & Johnson Boao Innovation Chain 2.0" Official Launch and Signing Ceremony for the "Neurosurgery Innovation Strategic Platform" Cooperation Intent

Focus on Healthcare Innovation, Upgrade Cooperation for a New Journey

The "Johnson & Johnson Baotou Innovation Chain" Embarks on a New Journey2.0" will integrate Johnson & Johnson withBoao Lecheng International Medical Tourism Pilot Zone leverages respective professional and resource advantages to further innovate cooperation models, expand cooperation areas, and enhance cooperation outcomes. Both parties will actively collaborate, centering on healthcare needs, to support the advancement of innovative project incubation and the transformation of scientific and technological achievements, thereby better meeting clinical needs. At the same time, both parties will also work together to promote industry standardization and regulation, advance the development of related disciplines, and facilitate the healthy development of the industry. Notably, both parties will also explore innovative ecosystem construction, jointly promoting the realization of the Healthy China goals.。

Jia Ning, Secretary of the Party Committee and Director of the Administration Bureau of Boao Lecheng International Medical Tourism Pilot Zone in Hainan, stated: "Johnson & Johnson is an ‘old friend’ of Lecheng Pilot Zone. We are very pleased to promote the aggregation of high-quality medical resources and improve the industrial system through a series of innovative projects with high technological content and strong radiating driving force. The Lecheng Administration Bureau will, as always, support the development of various medical technology innovation projects, promote the transformation and implementation of more medical technology innovation achievements in the Lecheng Pilot Zone, and contribute to the high-quality development of the healthcare industry."

"Johnson & Johnson Baotou Innovation Chain""Brand New UpgradeIt is based on the solid foundation of cooperation and innovative achievements over the past three years.In 2019, the "Johnson & Johnson Boao Innovation Chain" was officially launched, dedicated to creating an innovative comprehensive platform integrating the display of medical research achievements, technology promotion, product application, academic exchange, and professional training. Over the past three years,Relying on the platform effect of Lecheng Pilot Zone,"The Johnson & Johnson Boao Innovation Chain" has developed into a bridge connecting medical needs in China with advanced global medical technologies and products, leading several "firsts" in the industry.". Its subsidiary 'Boao Surgery' is an authoritative academic brand in the field of Chinese surgery, providing standardized and normalized surgical guidance and leading clinical concepts to hundreds of thousands of surgeons in China, with millions of views and studies accumulated.

Accelerate the Medical-Engineering Transformation in the Industry, Promote Innovation and Development in the Industry

Against the backdrop of China's 14th Five-Year Plan and its commitment to innovation-driven development,The R&D model of combining medicine and engineering is becoming increasingly popular, routine, and standardized, accelerating the development of clinical disciplines and allowing innovative research to benefit more patients. The integration of medicine and engineering is not only an effective way to accelerate innovation and transformation but also an important trend in the future development of the healthcare industry. Among them, neurosurgery is one of the most specialized and practically challenging specialties in the broader surgical system. InDuring the process of discipline construction and industry development,How to BetterEstablishing an authoritative, standardized, and reasonable evaluation system for innovative projects to drive the transformation of innovations in the field of neurosurgery, empowering clinical needs, and ultimately providing better treatment options for patients requires the joint efforts and continuous exploration of all parties in the industry.

To this end, Johnson & Johnson Medical Technology and Hainan Boao Real-World Research Institute signed a letter of intent to cooperate, planning to launch the "Neurosurgery Innovation Ecosystem Strategic Platform." Relying on the "Johnson & Johnson Boao Innovation Chain 2.0," the platform will focus on clinical innovation needs in neurosurgery, exploring new ideas, measures, and pathways for technological innovation and achievement transformation. At the same time, it will focus on the construction of innovative mechanisms, collaborate with relevant parties, and actively promote the construction of the neurosurgery innovation ecosystem, covering every aspect from the innovation capacity building of doctors and researchers to the entire process of innovative projects.

Professor Mao Ying, President of Huashan Hospital Affiliated to Fudan University, said:"With the rapid development of neuro-medical technology, the innovative transformation of neuro-medicine has entered a critical period of development opportunities. Integrating the concept of precision diagnosis and treatment with engineering technology is an inevitable trend in the industry's development. The establishment of the 'Neurosurgery Innovation Ecosystem Strategy Platform'..."Capable of promoting the clinical transformation and application of innovative technologies and products, allowing innovative achievements to enter the market more quickly and benefit more patients.”

Johnson & Johnson was one of the first multinational healthcare companies to partner with the Boao Lecheng Pilot Zone to introduce cutting-edge international innovative products into the zone.The latest upgrade of the "Johnson & Johnson Boao Innovation Chain" marks a new phase in the development of the collaboration between both parties, further promoting high-quality growth in the healthcare industry and enhancing the health and well-being of the people.

Song Weiqun, Global Senior Vice President of Johnson & Johnson and Chairman of Johnson & Johnson China, stated: "Over the more than thirty years since entering the Chinese market, Johnson & Johnson has continuously driven development through innovation. Leveraging our global resources and professional advantages, we have consistently introduced advanced technologies and products to benefit a wide range of patients. In the future, Johnson & Johnson will continue to actively explore diverse cooperation models, collaborate with all parties, and jointly build a strong innovative ecosystem, thereby promoting the development of the entire healthcare industry and contributing to the realization of 'Healthy China.'""Contribute to the grand vision of 2030.'"